MyFinsight
Home
About
Contact
crsp: the income statement
Download
Download image
Comprehensive loss
-$105,496K
(-45.52%↓ Y/Y)
Unrealized gain on
marketable securities
$973K
(-92.72%↓ Y/Y)
Foreign currency
translation adjustment
-$28K
(-136.84%↓ Y/Y)
Net loss
-$106,441K
(-23.85%↓ Y/Y)
Other income, net
$26,237K
(4.68%↑ Y/Y)
Provision for income taxes
$619K
(-29.34%↓ Y/Y)
Net loss before
income taxes
-$105,822K
(-24.40%↓ Y/Y)
Total other income,
net
$26,237K
(4.68%↑ Y/Y)
Grant
$889K
Loss from operations
-$132,059K
(-19.91%↓ Y/Y)
Total revenue
$889K
(47.67%↑ Y/Y)
Total operating
expenses
$132,948K
(20.06%↑ Y/Y)
Collaboration expense, net
$57,115K
(412.10%↑ Y/Y)
General and
administrative
$16,931K
(-2.80%↓ Y/Y)
Research and development
$58,902K
(-28.31%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP)